Nanoparticles - Metal & Metal Oxides Market In Healthcare By Type (Gold, Silver, Iron Oxide, Alumina, Gadolinium, Cerium), By Application (In-vivo Imaging, Targeted Drug Delivery, Proton Therapy, In-vitro assays), & Segment Forecasts, 2018 - 2025Report

Nanoparticles - Metal & Metal Oxides Market In Healthcare By Type (Gold, Silver, Iron Oxide, Alumina, Gadolinium, Cerium), By Application (In-vivo Imaging, Targeted Drug Delivery, Proton Therapy, In-vitro assays), & Segment Forecasts, 2018 - 2025

  • Report ID: GVR-1-68038-805-3
  • Number of Pages: 142
  • Format: Electronic (PDF)
  • Historical Range: 2013 - 2016
  • Industry: Healthcare

Table of Contents

Chapter 1 Research Methodology
                1.1 Information Procurement
                1.2 Data Analysis
Chapter 2 Executive Summary
                2.1 Market Snapshot
Chapter 3 Nanoparticles - Metal & Metal Oxides Market Variables, Trends& Scope
                3.1 Market segmentation & scope
                    3.1.1 Market Driver Analysis
                        3.1.1.1 Substantial number of nanoparticle-based therapeutics and pharmaceuticals in R&D
                        3.1.1.2 Growing utility potential of metal nanoparticles in cancer and other diseases treatment
                        3.1.1.3 Rapid advances in analytical methods for detection and evaluation of nanoparticles
                    3.1.2 Market Restraint Analysis
                        3.1.2.1 Toxicity and environmental risks of metal nanomaterials
                        3.1.2.2 Regulatory issues pertaining to the use and approval of metal nanoparticles
                3.2 Penetration & growth prospect mapping for type of nanoparticles, 2016
                3.3 Nanoparticles - Metal & Metal Oxides Market - SWOT Analysis, By Factor (political & legal, economic and technological)
                3.4 Industry Analysis - Porter’s
                3.5 Metal & Metal Oxide Nanoparticles Pipeline Analysis
                    3.5.1 Arrowhead Pharmaceuticals
                    3.5.2 Nanobiotix
                    3.5.3 BIND Biosciences
                    3.5.4 CELGENE CORPORATION
                    3.5.5 CYTIMMUNE SCIENCES, INC
                    3.5.6 Siteman Center of Cancer Nanotechnology Excellence (Washington University CCNE)
                    3.5.7 Centers of Cancer Nanotechnology Excellence
Chapter 4 Nanoparticles - Metal & Metal Oxides: Type Estimates & Trend Analysis
                4.1 Metal & metal oxides nanoparticles in healthcare market: Type movement analysis
                4.2 Gold Nanoparticles
                    4.2.1 Global gold nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
                4.3 Silver Nanoparticles
                    4.3.1 Global silver nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
                4.4 Iron Oxide Nanoparticles
                    4.4.1 Global iron oxide nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
                4.5 Alumina Nanoparticles
                    4.5.1 Global alumina nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
                4.6 Gadolinium oxide nanoparticles
                    4.6.1 Global gadolinium oxide nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
                4.7 Others
                    4.7.1 Global other metal nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
Chapter 5 Nanoparticles - Metal & Metal Oxides: Application Estimates & Trend Analysis
                5.1 Metal & metal oxides nanoparticles in healthcare market: Application movement analysis
                5.2 In-vivo Imaging
                    5.2.1 Global in-vivo imaging market, 2013 - 2025 (USD Billion)
                5.3 Targeted Drug Delivery
                    5.3.1 Global targeted drug delivery market, 2013 - 2025 (USD Billion)
                5.4 Proton Therapy
                    5.4.1 Global proton therapy market, 2013 - 2025 (USD Billion)
                5.5 In-vitro Assays
                    5.5.1 Global in-vitro assays market, 2013 - 2025 (USD Billion)
                5.6 Cell & Phantom Imaging
                    5.6.1 Global cell & phantom imaging market, 2013 - 2025 (USD Billion)
Chapter 6 Nanoparticles - Metal & Metal Oxides: Regional Estimates & Trend Analysis, by Type& Application
                6.1 Metal & metal oxides nanoparticles in healthcare market share by region, 2016 & 2025
                6.2 North America
                    6.2.1 Metal & metal oxides nanoparticles in healthcare market, 2013 - 2025 (USD Billion)
                    6.2.2 The U.S.
                        6.2.2.1 Metal & metal oxides nanoparticles in healthcare market, by type, 2013 - 2025 (USD Billion)
                        6.2.2.2 Metal & metal oxides nanoparticles in healthcare market, by application, 2013 - 2025 (USD Billion)
                    6.2.3 Canada
                        6.2.3.1 Metal & metal oxides nanoparticles in healthcare market, by type, 2013 - 2025 (USD Billion)
                        6.2.3.2 Metal & metal oxides nanoparticles in healthcare market, by application, 2013 - 2025 (USD Billion)
                6.3 Europe
                    6.3.1 Metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
                    6.3.2 Germany
                        6.3.2.1 Metal & metal oxides nanoparticles in healthcare market, by type, 2013 - 2025 (USD Billion)
                        6.3.2.2 Metal & metal oxides nanoparticles in healthcare market, by application, 2013 - 2025 (USD Billion)
                    6.3.3 The U.K.
                        6.3.3.1 Metal & metal oxides nanoparticles in healthcare market, by type, 2013 - 2025 (USD Billion)
                        6.3.3.2 Metal & metal oxides nanoparticles in healthcare market, by application, 2013 - 2025 (USD Billion)
                6.4 Asia Pacific
                    6.4.1 Metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
                    6.4.2 Japan
                        6.4.2.1 Metal & metal oxides nanoparticles in healthcare market, by type, 2013 - 2025 (USD Billion)
                        6.4.2.2 Metal & metal oxides nanoparticles in healthcare market, by application, 2013 - 2025 (USD Billion)
                    6.4.3 China
                        6.4.3.1 Metal & metal oxides nanoparticles in healthcare market, by type, 2013 - 2025 (USD Billion)
                        6.4.3.2 Metal & metal oxides nanoparticles in healthcare market, by application, 2013 - 2025 (USD Billion)
                6.5 Latin America
                    6.5.1 Metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
                    6.5.2 Brazil
                        6.5.2.1 Metal & metal oxides nanoparticles in healthcare market, by type, 2013 - 2025 (USD Billion)
                        6.5.2.2 Metal & metal oxides nanoparticles in healthcare market, by application, 2013 - 2025 (USD Billion)
                6.6 Middle East & Africa
                    6.6.1 Metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
                    6.6.2 South Africa
                        6.6.2.1 Metal & metal oxides nanoparticles in healthcare market, by type, 2013 - 2025 (USD Billion)
                        6.6.2.2 Metal & metal oxides nanoparticles in healthcare market, by application, 2013 - 2025 (USD Billion)
Chapter 7 Competitive Landscape
                7.1 Strategy framework
                7.2 Market participation categorization
                7.3 Company Profiles
                    7.3.1 Immunolight LLC
                        7.3.1.1 Company overview
                        7.3.1.2 Financial performance
                        7.3.1.3 Product benchmarking
                    7.3.2 Merck KGaA
                        7.3.2.1 Company overview
                            7.3.2.1.1 Sigma-Aldrich Co. LLC
                        7.3.2.2 Financial performance
                            7.3.2.2.1 Financial performance
                        7.3.2.3 Product benchmarking
                        7.3.2.4 Strategic initiatives
                    7.3.3 CYTIMMUNE SCIENCES, INC.
                        7.3.3.1 Company overview
                        7.3.3.2 Financial performance
                        7.3.3.3 Product benchmarking
                        7.3.3.4 Strategic initiatives
                    7.3.4 CELGENE CORPORATION
                        7.3.4.1 Company overview
                            7.3.4.1.1 Abraxis BioScience, Inc.
                        7.3.4.2 Financial performance
                        7.3.4.3 Product benchmarking
                        7.3.4.4 Strategic initiatives
                    7.3.5 AstraZeneca
                        7.3.5.1 Company overview
                        7.3.5.2 Financial performance
                        7.3.5.3 Product benchmarking
                        7.3.5.4 Strategic initiatives
                    7.3.6 Brigham and Women's Hospital (BWH)
                        7.3.6.1 Company overview
                        7.3.6.1 Financial performance
                        7.3.6.2 Product benchmarking
                    7.3.7 Nanoprobes, Inc.
                        7.3.7.1 Company overview
                        7.3.7.2 Financial performance
                        7.3.7.3 Product benchmarking
                    7.3.8 Z-MEDICA
                        7.3.8.1 Company overview
                        7.3.8.2 Financial performance
                        7.3.8.3 Product benchmarking
                    7.3.9 Nanospectra Biosciences, Inc.
                        7.3.9.1 Company overview
                        7.3.9.2 Financial performance
                        7.3.9.3 Product benchmarking
                        7.3.9.4 Strategic initiatives
                    7.3.10 Nanobiotix
                        7.3.10.1 Company overview
                        7.3.10.2 Financial performance
                        7.3.10.3 Product benchmarking
                        7.3.10.4 Strategic initiatives
                    7.3.11 Oxonica
                        7.3.11.1 Company overview
                            7.3.11.1.1 Nanoplex Technologies, Inc.
                        7.3.11.2 Financial performance
                        7.3.11.3 Product benchmarking
                    7.3.12 Pfizer Inc.
                        7.3.12.1 Company overview
                            7.3.12.1.1 BIND Therapeutics
                        7.3.12.2 Financial performance
                        7.3.12.3 Product benchmarking
                        7.3.12.4 Strategic initiatives
                    7.3.13 nanoComposix
                        7.3.13.1 Company overview
                        7.3.13.2 Financial performance
                        7.3.13.3 Product benchmarking


List of Tables

TABLE 1 Clinical studies for metal nanoparticles based therapeutic solutions in 2015
TABLE 2 Search results of the U.S. databases using the term “nanoparticle” in combination with other terms
TABLE 3 Metal and metal oxide nanoparticles and cancer research
TABLE 4 In vitro/in vivo studies on toxicity of various types of metal nanoparticles
TABLE 5 Gold nanoparticles and their applications
TABLE 6 Role of superparamagnetic iron oxide nanoparticles in different areas of Magnetic Resonance Imaging (MRI)
TABLE 7 Active cancer-targeting strategies of magnetic nanoparticle
TABLE 8 North America metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 9 North America metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 10 North America metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 11 North America metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 12 Patent applicant for nanotechnology based therapeutics
TABLE 13 U.S. metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 14 U.S. metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 15 U.S. metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 16 U.S. metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 17 Nanotechnology organizations which are involved in publishing nanoscience based articles
TABLE 18 Canada metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 19 Canada metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 20 Canada metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 21 Canada metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 22 Europe metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 23 Europe metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 24 Europe metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 25 Europe metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 26 Germany metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 27 Germany metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 28 Germany metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 29 Germany metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 30 UK metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 31 UK metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 32 UK metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 33 UK metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 34 Asia Pacific metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 35 Asia Pacific metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 36 Asia Pacific metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 37 Asia Pacific metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 38 Japan metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 39 Japan metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 40 Japan metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 41 Japan metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 42 China metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 43 China metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 44 China metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 45 China metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 46 Latin America metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 47 Latin America metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 48 Latin America metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 49 Latin America metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 50 Brazil metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 51 Brazil metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 52 Brazil metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 53 Brazil metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 54 MEA metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 55 MEA metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 56 MEA metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 57 MEA metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
TABLE 58 South Africa metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
TABLE 59 South Africa metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
TABLE 60 South Africa metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
TABLE 61 South Africa metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)


List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Market restraint relevance analysis (Current & future impact)
FIG. 12 Penetration & growth prospect mapping for type of nanoparticles, 2016
FIG. 13 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 14 Porter’s Five Forces Analysis
FIG. 15 Metal & metal oxides nanoparticles in healthcare market type outlook key takeaways
FIG. 16 Metal & metal oxides nanoparticles in healthcare market: Type movement analysis
FIG. 17 Global gold nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
FIG. 18 Global silver nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
FIG. 19 Global iron oxide nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
FIG. 20 Global alumina nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
FIG. 21 Global gadolinium oxide nanoparticles market, 2013 - 2025 (USD Billion)
FIG. 22 Global other metal nanoparticles market, 2013 - 2025 (USD Billion)
FIG. 23 Metal & metal oxides nanoparticles in healthcare market: Application outlook key takeaways
FIG. 24 Global metal & metal oxides nanoparticles in healthcare: Application movement analysis
FIG. 25 Global in-vivo imaging market, 2013 - 2025 (USD Billion)
FIG. 26 Global targeted drug delivery market, 2013 - 2025 (USD Billion)
FIG. 27 Global proton therapy market, 2013 - 2025 (USD Billion)
FIG. 28 Global in-vitro assays market, 2013 - 2025 (USD Billion)
FIG. 29 Global cell & phantom imaging market, 2013 - 2025 (USD Billion)
FIG. 30 Regional market place: Key takeaway
FIG. 31 Metal & metal oxides nanoparticles in healthcare regional outlook, 2016 & 2025
FIG. 32 North America metal & metal oxides nanoparticles in healthcare market, 2013 - 2025 (USD Billion)
FIG. 33 U.S. metal & metal oxides nanoparticles in healthcare market, 2013 - 2025 (USD Billion)
FIG. 34 Canada. metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
FIG. 35 Europe metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
FIG. 36 Germany metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
FIG. 37 UK metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
FIG. 38 Asia Pacific metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
FIG. 39 Japan metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
FIG. 40 China metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
FIG. 41 Latin America metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
FIG. 42 Brazil metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
FIG. 43 Middle East & Africa metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
FIG. 44 South Africa metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
FIG. 45 Strategy framework
FIG. 46 Participant categorization

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon gvr sidebar D&B icon gvr sidebar

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.